SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 345, Issue 8941, 1995, Pages 29-30

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

(5) Howell, A a DeFriend, D J b Blamey, R W c Robertson, J F c Walton, P d

a UNIVERSITY OF MANCHESTER (United Kingdom)

b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST (United Kingdom)

c NOTTINGHAM CITY HOSPITAL (United Kingdom)

d ASTRAZENECA (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; FULVESTRANT; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DREAMING; DRUG RESISTANCE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIVER; PRIORITY JOURNAL; VAGINA BLEEDING;

EID: 0028861402 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(95)91156-1 Document Type: Article

Times cited : (317)

References (10)

1
- 0026395885
- A potent specific pure antioestrogen with clinical potential
- (1991) Cancer Res , vol.51 , pp. 3867-3873
- Wakeling¹ Dukes² Bowler³

2
- 0025084510
- Inhibition of oestrogen receptor-DNA binding by the "pure" antioestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization
- (1990) Proc Natl Acad Sci USA , vol.87 , pp. 6883-6887
- Fawell¹ White² Hoare³ Sydenham⁴ Page⁵ Parker⁶

3
- 0025062215
- Role of the two activating domains on the oestrogen receptor in the cell-type and promoter-context dependent agonist activity of the anti-oestrogen 4-hydroxytamoxifen
- (1990) EMBO J , vol.9 , pp. 2811-2818
- Berry¹ Metzger² Chambon³

4
- 0023708345
- The definition of the 'No change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast
- (1988) European Journal of Cancer and Clinical Oncology , vol.24 , pp. 1567-1572
- Howell¹ Macintosh² Jones³ Redford⁴ Wagstaff⁵ Sellwood⁶

5
- 0027409546
- Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer
- (1993) J Clin Oncol , vol.11 , pp. 345-350
- Vogel¹ Shemano² Schonfelder³ Gams⁴ Green⁵

6
- 0027933048
- Effects of 4-hydroxytamoxifen and a pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro
- (1994) Br J Cancer , vol.70 , pp. 204-211
- DeFriend¹ Anderson² Bell³ Wilks⁴ West⁵ Howell⁶

7
- 0026768801
- Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
- (1992) Ann Oncol , vol.3 , pp. 611-617
- Howell¹ Dodwell² Anderson³ Redford⁴

8
- 0026068370
- Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen
- (1991) J Natl Cancer Inst , vol.83 , pp. 1477-1482
- Osborne¹ Coronado² Allred³

9
- 0026646778
- Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antioestrogen binding site activity
- (1992) Cancer Res , vol.52 , pp. 4106-4112
- Pavlik¹ Nelson² Srinivasan³

10
- 0027971917
- The effects of ICI 182780, a pure antioestrogen, on the hypothalamic-pituitary-gonadalaxis and on endometrial proliferation in premenopausal women
- (in press)
- (1994) Hum Reprod , vol.9
- Thomas¹ Walton² Thomas³ Dowsett⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.